MedTrace Logo

50 Human Subject Repeat Insult Patch Test

NCT04498676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-08-04

No results posted yet for this study

Summary

Consumer products or raw materials designed for consistent reapplication to areas of the skin may, under proper conditions, prove to be contact sensitizers or irritants in certain individuals. It is the intention of a Repeat Insult Patch Test (RIPT) to provide a basis for evaluation of this irritation/sensitization potential if such exists.

Conditions

  • Erythema
  • Sensitisation

Interventions

OTHER

CB-0002B

CB-0002B (choline geranate) is a viscous transparent colorless to light yellow liquid

Sponsors & Collaborators

  • AMA Laboratories Inc.

    collaborator UNKNOWN

  • CAGE Bio Inc.

    lead INDUSTRY

Principal Investigators

  • Director · AMA Laboratories Inc.

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2017-02-08
Completion
2017-03-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04498676 on ClinicalTrials.gov